MR imaging is indicated for mad cow disease diagnosis

Article

RI should be included among the World Health Organization's options for diagnosing sporadic Creutzfeldt-Jakob disease, which is associated with exposure to mad cow disease, according to Dr. Henriette Tschampa and colleagues at the Clinical University of Bonn, Germany.

MRI should be included among the World Health Organization's options for diagnosing sporadic Creutzfeldt-Jakob disease, which is associated with exposure to mad cow disease, according to Dr. Henriette Tschampa and colleagues at the Clinical University of Bonn, Germany.

The researchers enrolled 193 consecutive patients suspected of having the condition. In 442 scans, MR's sensitivity and specificity were nearly 70% and 85%, respectively, in patients with a clinical or postmortem sCJD diagnosis. Sensitivity and specificity for EEG and 14-3-3 protein analysis were 32% and 94%, and 91% and 44%, respectively, they reported at the RSNA meeting. Even though interpretation of MR scans may require some effort, the modality provides useful information that could narrow down an sCJD diagnosis.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.